Literature DB >> 27664414

PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude.

Eleni Magdalini Kyritsi1, George K Dimitriadis1,2,3, Ioannis Kyrou1,2,4, Gregory Kaltsas1,5, Harpal S Randeva1,2,4.   

Abstract

Polycystic ovarian syndrome (PCOS) is a heterogenous disorder associated with clinical, endocrine and ultrasonographic features that can also be encountered in a number of other diseases. It has traditionally been suggested that prolactin excess, enzymatic steroidogenic abnormalities and thyroid disorders need to be excluded before a diagnosis of PCOS is made. However, there is paucity of data regarding the prevalence of PCOS phenotype in some of these disorders, whereas other endocrine diseases that exhibit PCOS-like features may elude diagnosis and proper management if not considered. This article reviews the data of currently included entities that exhibit a PCOS phenotype and those that potentially need to be looked for, and attempts to identify specific features that distinguish them from idiopathic PCOS.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27664414     DOI: 10.1111/cen.13245

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  An update of polycystic ovary syndrome: causes and therapeutics options.

Authors:  Abeer M Rababa'h; Bayan R Matani; Alaa Yehya
Journal:  Heliyon       Date:  2022-10-10

2.  Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy.

Authors:  Fatin Shallal Farhan; Shatha Sami Hussien
Journal:  J Obstet Gynaecol India       Date:  2018-09-15

Review 3.  The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Hassan Kahal; Ioannis Kyrou; Olalekan A Uthman; Anna Brown; Samantha Johnson; Peter D H Wall; Andrew Metcalfe; David G Parr; Abd A Tahrani; Harpal S Randeva
Journal:  Sleep Breath       Date:  2019-05-20       Impact factor: 2.816

Review 4.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

5.  Sleep Disruption and Depression, Stress and Anxiety Levels in Women With Polycystic Ovary Syndrome (PCOS) During the Lockdown Measures for COVID-19 in the UK.

Authors:  Chris Kite; Lou Atkinson; Gordon McGregor; Cain C T Clark; James E Brown; Ioannis Kyrou; Harpal S Randeva
Journal:  Front Glob Womens Health       Date:  2021-06-04

Review 6.  An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Authors:  Hiya Islam; Jaasia Masud; Yushe Nazrul Islam; Fahim Kabir Monjurul Haque
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

7.  Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes.

Authors:  Lauren E Chan; Elena Casiraghi; Bryan Laraway; Ben Coleman; Hannah Blau; Adnin Zaman; Nomi Harris; Kenneth Wilkins; Michael Gargano; Giorgio Valentini; David Sahner; Melissa Haendel; Peter N Robinson; Carolyn Bramante; Justin Reese
Journal:  medRxiv       Date:  2022-08-30

Review 8.  Disorders of the adrenal cortex: Genetic and molecular aspects.

Authors:  Georgia Pitsava; Andrea G Maria; Fabio R Faucz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

9.  Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: study protocol for a randomized controlled trial.

Authors:  Cheng-Ming Ni; Wen-Long Huang; Yan-Min Jiang; Juan Xu; Ru Duan; Yun-Long Zhu; Xu-Ping Zhu; Xue-Mei Fan; Guo-An Luo; Yi-Ming Wang; Yan-Yu Li; Qing He; Lan Xu
Journal:  Trials       Date:  2020-02-11       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.